Participants 67 85 4
patients with GERD
Participants 172 224 6
patients with gastroesophageal reflux disease (GERD)
Participants 475 609 3
adults with GERD-associated sleep disturbances and moderate-to-severe nighttime heartburn (recorded by patient diary during screening)
Participants 611 722 4
Patients received oral esomeprazole 40 mg (n = 220) or 20 mg (n = 226) or placebo (n = 229) once daily for 4 wk
